Avanos Medical (AVNS) Invested Capital (2013 - 2026)

Avanos Medical has disclosed Invested Capital across 14 years of filings, most recently posting $880.3 million for Q1 2026.

• In Q1 2026, Invested Capital fell 7.02% year-over-year to $880.3 million; the TTM figure through Mar 2026 stood at $880.3 million (down 7.02% YoY), while the FY2025 annual figure was $878.7 million, down 8.77% from the prior year.
• Invested Capital came in at $880.3 million for Q1 2026 at Avanos Medical, roughly flat from $878.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.5 billion in Q4 2022 to a low of $878.7 million in Q4 2025.
• Average Invested Capital over 5 years is $1.3 billion, with a median of $1.4 billion recorded in 2023.
• Year-over-year, Invested Capital rose 8.79% in 2022 and tumbled 36.91% in 2025.
• Over 5 years, Invested Capital stood at $1.5 billion in 2022, then retreated by 7.84% to $1.4 billion in 2023, then tumbled by 31.41% to $963.2 million in 2024, then declined by 8.77% to $878.7 million in 2025, then grew by 0.18% to $880.3 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $880.3 million in Q1 2026, $878.7 million in Q4 2025, and $880.8 million in Q3 2025.